{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T01:32:57Z","timestamp":1772674377587,"version":"3.50.1"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2022,10,1]]},"abstract":"<jats:sec id=\"ab-eoi220054-4\"><jats:title>Importance<\/jats:title><jats:p>Visual impairment is an irreversible adverse effect in individuals who experienced a childhood brain tumor. Ophthalmological evaluation at diagnosis enables early detection of vision loss, decision-making about treatment, and when applicable, the timely use of visual interventions. However, awareness of visual impairment in clinical practice is suboptimal, and adherence to ophthalmological evaluation needs to be improved.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi220054-5\"><jats:title>Objective<\/jats:title><jats:p>To assess the prevalence and types of abnormal ophthalmological findings in youths with a newly diagnosed brain tumor.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi220054-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>In this nationwide, prospective cohort study, youths aged 0 to 18 years with a newly diagnosed brain tumor between May 15, 2019, and August 11, 2021, were consecutively enrolled in 4 hospitals in the Netherlands, including the dedicated tertiary referral center for pediatric oncology care.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi220054-7\"><jats:title>Exposures<\/jats:title><jats:p>A standardized and comprehensive ophthalmological examination, including orthoptic evaluation, visual acuity testing, visual field examination, and ophthalmoscopy, was performed within 4 weeks from brain tumor diagnosis.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi220054-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The main outcomes were prevalence and types of visual symptoms and abnormal ophthalmological findings at brain tumor diagnosis.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi220054-9\"><jats:title>Results<\/jats:title><jats:p>Of 170 youths included in the study (96 [56.5%] male; median age, 8.3 years [range, 0.2-17.8 years]), 82 (48.2%) had infratentorial tumors; 53 (31.2%), supratentorial midline tumors; and 35 (20.6%), cerebral hemisphere tumors. A total of 161 patients (94.7%) underwent orthoptic evaluation (67 [41.6%] preoperatively; 94 [58.4%] postoperatively); 152 (89.4%), visual acuity testing (63 [41.4%] preoperatively; 89 [58.6%] postoperatively); 121 (71.2%), visual field examination (49 [40.4%] preoperatively; 72 [59.6%] postoperatively); and 164 (96.5%), ophthalmoscopy (82 [50.0%] preoperatively; 82 [50.0%] postoperatively). Overall, 101 youths (59.4%) presented with visual symptoms at diagnosis. Abnormal findings were found in 134 patients (78.8%) during ophthalmological examination. The most common abnormal findings were papilledema in 86 of 164 patients (52.4%) who underwent ophthalmoscopy, gaze deficits in 54 of 161 (33.5%) who underwent orthoptic evaluation, visual field defects in 32 of 114 (28.1%) with reliable visual field examination, nystagmus in 40 (24.8%) and strabismus in 32 (19.9%) of 161 who underwent orthoptic evaluation, and decreased visual acuity in 13 of 152 (8.6%) with reliable visual acuity testing. Forty-five of 69 youths (65.2%) without visual symptoms at diagnosis had ophthalmological abnormalities on examination.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi220054-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>The results of this study suggest that there is a high prevalence of abnormal ophthalmological findings in youths at brain tumor diagnosis regardless of the presence of visual symptoms. These findings support the need of standardized ophthalmological examination and the awareness of ophthalmologists and referring oncologists, neurologists, and neurosurgeons for ophthalmological abnormalities in this patient group.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2022.3628","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T15:02:37Z","timestamp":1663254157000},"page":"982","source":"Crossref","is-referenced-by-count":16,"title":["Ophthalmological Findings in Youths With a Newly Diagnosed Brain Tumor"],"prefix":"10.1001","volume":"140","author":[{"given":"Myrthe A.","family":"Nuijts","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University Medical Center Utrecht, Utrecht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"Stegeman","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Medical Center Utrecht, Utrecht, the Netherlands"},{"name":"Department of Otorhinolaryngology and Head & Neck Surgery University, University Medical Center Utrecht, Utrecht, the Netherlands"},{"name":"Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands"},{"name":"Epidemiology and Data Science, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"van Seeters","sequence":"additional","affiliation":[{"name":"Department of Radiology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marloes D.","family":"Borst","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Utrecht University, Utrecht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlien A. M.","family":"Bennebroek","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, location AMC of Amsterdam University Medical Center, Amsterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis R.","family":"Buis","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurosurgery, location AMC of Amsterdam University Medical Center, Amsterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole C.","family":"Naus","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio L.","family":"Porro","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Medical Center Utrecht, Utrecht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle B.","family":"van Egmond-Ebbeling","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Medical Center Utrecht, Utrecht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth S. M.","family":"Voskuil-Kerkhof","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Medical Center Utrecht, Utrecht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JanWillem R.","family":"Pott","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels E.","family":"Franke","sequence":"additional","affiliation":[{"name":"Department of Neuro-Oncology, Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelien","family":"de Vos-Kerkhof","sequence":"additional","affiliation":[{"name":"Department of Neuro-Oncology, Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eelco W.","family":"Hoving","sequence":"additional","affiliation":[{"name":"Department of Neuro-Oncology, Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoinette Y. N.","family":"Schouten-van Meeteren","sequence":"additional","affiliation":[{"name":"Department of Neuro-Oncology, Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia M.","family":"Imhof","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Medical Center Utrecht, Utrecht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"12","key":"eoi220054r2","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017.","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro Oncol"},{"issue":"13","key":"eoi220054r3","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1093\/jnci\/djp148","article-title":"Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study.","volume":"101","author":"Armstrong","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"eoi220054r4","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00381-012-1707-y","article-title":"Intracranial tumors in infants: long-term functional outcome, survival, and its predictors.","volume":"28","author":"Pillai","year":"2012","journal-title":"Childs Nerv Syst"},{"issue":"9","key":"eoi220054r5","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1002\/pbc.25064","article-title":"Late effects in survivors of childhood CNS tumors treated on Head Start I and II protocols.","volume":"61","author":"Saha","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"eoi220054r6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/WCO.0000000000000644","article-title":"Visual function in children with primary brain tumors.","volume":"32","author":"Peragallo","year":"2019","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"eoi220054r7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.spen.2017.04.007","article-title":"A review of visual and oculomotor outcomes in children with posterior fossa tumors.","volume":"24","author":"Peeler","year":"2017","journal-title":"Semin Pediatr Neurol"},{"issue":"5","key":"eoi220054r9","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/cncr.v122.5","article-title":"Impact of vision loss among survivors of childhood central nervous system astroglial tumors.","volume":"122","author":"de Blank","year":"2016","journal-title":"Cancer"},{"issue":"2","key":"eoi220054r10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11060-013-1300-6","article-title":"Vision specific quality of life in children with optic pathway gliomas.","volume":"116","author":"Avery","year":"2014","journal-title":"J Neurooncol"},{"issue":"1","key":"eoi220054r12","first-page":"1","author":"Nuijts","year":"2021","journal-title":"J Neuro-Ophthalmology"},{"issue":"8","key":"eoi220054r13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.8273","article-title":"Referral for ophthalmology evaluation and visual sequelae in children with primary brain tumors.","volume":"2","author":"Liu","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"eoi220054r14","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s11060-018-2762-3","article-title":"Long-term visual outcomes of craniopharyngioma in children.","volume":"137","author":"Wan","year":"2018","journal-title":"J Neurooncol"},{"issue":"6","key":"eoi220054r15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1530\/EJE-17-0044","article-title":"Very long-term sequelae of craniopharyngioma.","volume":"176","author":"Wijnen","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"eoi220054r16","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26543","article-title":"Visual complaints in intracranial germinomas.","volume":"64","author":"Frappaz","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"eoi220054r17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/neuonc\/noaa153","article-title":"NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat.","volume":"23","author":"Azizi","year":"2021","journal-title":"Neuro Oncol"},{"issue":"10","key":"eoi220054r18","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1136\/bjophthalmol-2017-311305","article-title":"Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort.","volume":"102","author":"Falzon","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"eoi220054r19","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/01658107.2019.1597130","article-title":"The management of childhood intracranial tumours and the role of the ophthalmologist.","volume":"43","author":"Mole","year":"2019","journal-title":"Neuroophthalmology"},{"issue":"3","key":"eoi220054r20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4103\/0974-9233.159739","article-title":"Ophthalmic features of outpatient children diagnosed with intracranial space-occupying lesions by ophthalmologists.","volume":"22","author":"Alswaina","year":"2015","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"1","key":"eoi220054r21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12886-019-1225-8","article-title":"Visual impairment in children with a brain tumor: a prospective nationwide multicenter study using standard visual testing and optical coherence tomography (CCISS study).","volume":"19","author":"Nuijts","year":"2019","journal-title":"BMC Ophthalmol"},{"issue":"20","key":"eoi220054r22","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"6","key":"eoi220054r23","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary.","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"1","key":"eoi220054r24","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdaa094","article-title":"Long-term cognitive deficits in pediatric low-grade glioma (LGG) survivors reflect pretreatment conditions-report from the German LGG studies.","volume":"2","author":"Traunwieser","year":"2020","journal-title":"Neurooncol Adv"},{"issue":"970","key":"eoi220054r25","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1259\/bjr\/65246351","article-title":"Radiological classification of optic pathway gliomas: experience of a modified functional classification system.","volume":"81","author":"Taylor","year":"2008","journal-title":"Br J Radiol"},{"issue":"6","key":"eoi220054r26","doi-asserted-by":"publisher","first-page":"e963","DOI":"10.1111\/aos.v99.6","article-title":"A novel excel sheet conversion tool from Snellen fraction to logMAR including \u2018counting fingers\u2019, \u2018hand movement\u2019, \u2018light perception\u2019 and \u2018no light perception\u2019 and focused review of literature of low visual acuity reference values.","volume":"99","author":"Moussa","year":"2021","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"eoi220054r27","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1001\/archophthalmol.2010.94","article-title":"Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale.","volume":"128","author":"Scott","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"eoi220054r28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1001\/jamaophthalmol.2014.5257","article-title":"Perimetry in young and neurologically impaired children: the Behavioral Visual Field (BEFIE) Screening Test revisited.","volume":"133","author":"Koenraads","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"eoi220054r29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/BF00149155","article-title":"The Peritest, a new automatic and semi-automatic perimeter.","volume":"5","author":"Greve","year":"1982","journal-title":"Int Ophthalmol"},{"issue":"6","key":"eoi220054r30","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3928\/0191-3913-19911101-07","article-title":"Visual fields in 4- to 10-year-old children using Goldmann and double-arc perimeters.","volume":"28","author":"Quinn","year":"1991","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"2","key":"eoi220054r31","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1067\/mpa.2001.113840","article-title":"SITA visual field testing in children.","volume":"5","author":"Donahue","year":"2001","journal-title":"J AAPOS"},{"issue":"2","key":"eoi220054r33","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1136\/bjophthalmol-2016-309402","article-title":"Study of Optimal Perimetric Testing In Children (OPTIC): development and feasibility of the Kinetic Perimetry Reliability Measure (KPRM).","volume":"101","author":"Patel","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"eoi220054r34","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1001\/archopht.1959.00940090601015","article-title":"Ocular findings in brain tumors in children.","volume":"61","author":"Carbajal","year":"1959","journal-title":"AMA Arch Ophthalmol"},{"issue":"2","key":"eoi220054r35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/PEC.0000000000000074","article-title":"Presenting symptoms of pediatric brain tumors diagnosed in the emergency department.","volume":"30","author":"Lanphear","year":"2014","journal-title":"Pediatr Emerg Care"},{"issue":"12","key":"eoi220054r36","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s00381-017-3572-1","article-title":"Presentation and symptom interval in children with central nervous system tumors: a single-center experience.","volume":"33","author":"Stocco","year":"2017","journal-title":"Childs Nerv Syst"},{"issue":"8","key":"eoi220054r37","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S1470-2045(07)70207-3","article-title":"Presentation of childhood CNS tumours: a systematic review and meta-analysis.","volume":"8","author":"Wilne","year":"2007","journal-title":"Lancet Oncol"},{"issue":"4","key":"eoi220054r38","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.survophthal.2019.01.010","article-title":"Interventions to improve functioning, participation, and quality of life in children with visual impairment: a systematic review.","volume":"64","author":"Elsman","year":"2019","journal-title":"Surv Ophthalmol"},{"key":"eoi220054r8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/b109924_12","volume-title":"Late Effects of Treatment for Brain Tumors","author":"Echevarr\u00eda","year":"2009"},{"key":"eoi220054r11","volume-title":"Pediatric Ophthalmology and Strabismus","author":"American Academy of Ophthalmology","year":"2019"},{"key":"eoi220054r32","volume-title":"Optic Neuropathies","author":"Biousse","year":"2015","edition":"2nd ed"},{"key":"eoi220054r1","unstructured":"Howlader? N, Noone? AM, Krapcho? M, . SEER cancer statistics review, 1975-2018. National Cancer Institute. 2021. Accessed January 13, 2022.https:\/\/seer.cancer.gov\/csr\/1975_2018\/"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2796317\/jamaophthalmology_nuijts_2022_oi_220054_1666118362.91807.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T15:04:07Z","timestamp":1666278247000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2796317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.3628","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,1]]}}}